Our Director of Pharmaceutical Operations and Pharma Business Lead, Dr. Reshma Ramracheya, recently organised and chaired an international symposium entitled “Unravelling the Mysteries of Diabetes: Challenges, Complications and Future Directions”.The symposium, held in partnership with the International Conference on Pure and Applied Chemistry (ICPAC) 2018 and the University of Mauritius and in collaboration with the University of Oxford where Dr Ramracheya has been studying the molecular mechanisms of diabetes for several years, aimed at increasing knowledge of diabetes from prevention to treatment. This threefold workshop focused on the risk factors of diabetes, from genetic predisposition to lifestyle, illustrated the clinical care recommended for impaired blood glucose control and main complications of diabetes such as retinopathy and foot ulcers, showcased current diabetes research, from its state of art to future perspectives, exploring the latest advances in drug development, surgical treatment of diabetes and clinical trials and finally, it served as an interactive platform for all stakeholders.Reshma is an islet physiologist with 18 years of experience in diabetes research and academic industry. She has been a Principal Investigator at the University of Oxford with a strong background in translational research in type 2 diabetes, obesity, weight-loss surgery, and cellular, animal and human research models. During the one-day symposium which took place on 5 July 2018, a team of international experts in clinical diabetes joined her for the first time in Mauritius, an island facing a massive burden of diabetes and related complications both in the young and adult populations. According to the World Health Organisation, in 2017 Mauritius ranked number 2 worldwide for diabetes-associated deaths, illustrating the proportion of the epidemic of diabetes in the island.